nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2E1—Dacarbazine—melanoma	0.141	0.256	CbGbCtD
Thioridazine—CYP1A2—Carmustine—melanoma	0.134	0.244	CbGbCtD
Thioridazine—CYP1A2—Vemurafenib—melanoma	0.106	0.193	CbGbCtD
Thioridazine—CYP2D6—Vemurafenib—melanoma	0.0875	0.159	CbGbCtD
Thioridazine—CYP1A2—Dacarbazine—melanoma	0.0814	0.148	CbGbCtD
Thioridazine—Hepatotoxicity—Vemurafenib—melanoma	0.00517	0.0339	CcSEcCtD
Thioridazine—Eruption—Dactinomycin—melanoma	0.00367	0.024	CcSEcCtD
Thioridazine—Photosensitivity—Vemurafenib—melanoma	0.0033	0.0216	CcSEcCtD
Thioridazine—Hepatotoxicity—Dactinomycin—melanoma	0.00292	0.0191	CcSEcCtD
Thioridazine—Hepatotoxicity—Carmustine—melanoma	0.00273	0.0179	CcSEcCtD
Thioridazine—Extrapyramidal disorder—Temozolomide—melanoma	0.00271	0.0178	CcSEcCtD
Thioridazine—Cholestasis—Temozolomide—melanoma	0.00269	0.0176	CcSEcCtD
Thioridazine—Hepatotoxicity—Temozolomide—melanoma	0.00264	0.0173	CcSEcCtD
Thioridazine—Eosinophilia—Vemurafenib—melanoma	0.00248	0.0163	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Docetaxel—melanoma	0.00245	0.0161	CcSEcCtD
Thioridazine—Menstruation irregular—Docetaxel—melanoma	0.00245	0.0161	CcSEcCtD
Thioridazine—Amenorrhoea—Temozolomide—melanoma	0.00232	0.0152	CcSEcCtD
Thioridazine—Photosensitivity reaction—Vemurafenib—melanoma	0.00229	0.015	CcSEcCtD
Thioridazine—Eruption—Docetaxel—melanoma	0.0022	0.0145	CcSEcCtD
Thioridazine—Aplastic anaemia—Dactinomycin—melanoma	0.00212	0.0139	CcSEcCtD
Thioridazine—Oedema peripheral—Vemurafenib—melanoma	0.00197	0.0129	CcSEcCtD
Thioridazine—Aplastic anaemia—Temozolomide—melanoma	0.00191	0.0126	CcSEcCtD
Thioridazine—Gynaecomastia—Carmustine—melanoma	0.00189	0.0124	CcSEcCtD
Thioridazine—Hepatotoxicity—Docetaxel—melanoma	0.00176	0.0115	CcSEcCtD
Thioridazine—Erythema—Vemurafenib—melanoma	0.00174	0.0114	CcSEcCtD
Thioridazine—Lethargy—Dactinomycin—melanoma	0.00167	0.011	CcSEcCtD
Thioridazine—Nasal congestion—Temozolomide—melanoma	0.00162	0.0107	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Temozolomide—melanoma	0.00157	0.0103	CcSEcCtD
Thioridazine—Amenorrhoea—Docetaxel—melanoma	0.00154	0.0101	CcSEcCtD
Thioridazine—Pancytopenia—Bleomycin—melanoma	0.00144	0.00944	CcSEcCtD
Thioridazine—Pancytopenia—Dactinomycin—melanoma	0.00134	0.00881	CcSEcCtD
Thioridazine—Hypotension—Vemurafenib—melanoma	0.00133	0.00872	CcSEcCtD
Thioridazine—Pancytopenia—Carmustine—melanoma	0.00126	0.00824	CcSEcCtD
Thioridazine—Sweating increased—Temozolomide—melanoma	0.00125	0.00817	CcSEcCtD
Thioridazine—Decreased appetite—Vemurafenib—melanoma	0.00124	0.00811	CcSEcCtD
Thioridazine—Constipation—Vemurafenib—melanoma	0.00122	0.00798	CcSEcCtD
Thioridazine—Pancytopenia—Temozolomide—melanoma	0.00122	0.00797	CcSEcCtD
Thioridazine—Agranulocytosis—Dactinomycin—melanoma	0.00118	0.00772	CcSEcCtD
Thioridazine—Photosensitivity reaction—Temozolomide—melanoma	0.00117	0.00766	CcSEcCtD
Thioridazine—Weight increased—Temozolomide—melanoma	0.00116	0.00763	CcSEcCtD
Thioridazine—Body temperature increased—Vemurafenib—melanoma	0.00113	0.00738	CcSEcCtD
Thioridazine—Erythema—Bleomycin—melanoma	0.00106	0.00693	CcSEcCtD
Thioridazine—Hypersensitivity—Vemurafenib—melanoma	0.00105	0.00688	CcSEcCtD
Thioridazine—Oedema peripheral—Carmustine—melanoma	0.00104	0.00684	CcSEcCtD
Thioridazine—Oedema peripheral—Temozolomide—melanoma	0.00101	0.00661	CcSEcCtD
Thioridazine—Lethargy—Docetaxel—melanoma	0.001	0.00659	CcSEcCtD
Thioridazine—Erythema—Dactinomycin—melanoma	0.000986	0.00646	CcSEcCtD
Thioridazine—Anaemia—Bleomycin—melanoma	0.000977	0.0064	CcSEcCtD
Thioridazine—Diarrhoea—Vemurafenib—melanoma	0.000974	0.00639	CcSEcCtD
Thioridazine—Arrhythmia—Carmustine—melanoma	0.000947	0.00621	CcSEcCtD
Thioridazine—Leukopenia—Bleomycin—melanoma	0.000946	0.0062	CcSEcCtD
Thioridazine—Mental disorder—Carmustine—melanoma	0.000928	0.00609	CcSEcCtD
Thioridazine—Erythema—Carmustine—melanoma	0.000922	0.00605	CcSEcCtD
Thioridazine—Anaemia—Dactinomycin—melanoma	0.000911	0.00597	CcSEcCtD
Thioridazine—Vomiting—Vemurafenib—melanoma	0.000905	0.00594	CcSEcCtD
Thioridazine—Rash—Vemurafenib—melanoma	0.000898	0.00589	CcSEcCtD
Thioridazine—Mental disorder—Temozolomide—melanoma	0.000897	0.00588	CcSEcCtD
Thioridazine—Dermatitis—Vemurafenib—melanoma	0.000897	0.00588	CcSEcCtD
Thioridazine—Headache—Vemurafenib—melanoma	0.000892	0.00585	CcSEcCtD
Thioridazine—Erythema—Temozolomide—melanoma	0.000891	0.00585	CcSEcCtD
Thioridazine—Leukopenia—Dactinomycin—melanoma	0.000882	0.00578	CcSEcCtD
Thioridazine—Confusional state—Bleomycin—melanoma	0.00087	0.0057	CcSEcCtD
Thioridazine—Vision blurred—Carmustine—melanoma	0.000869	0.0057	CcSEcCtD
Thioridazine—Tremor—Carmustine—melanoma	0.000864	0.00567	CcSEcCtD
Thioridazine—Oedema—Bleomycin—melanoma	0.000863	0.00566	CcSEcCtD
Thioridazine—Anaemia—Carmustine—melanoma	0.000853	0.00559	CcSEcCtD
Thioridazine—Agitation—Carmustine—melanoma	0.000848	0.00556	CcSEcCtD
Thioridazine—Nausea—Vemurafenib—melanoma	0.000846	0.00554	CcSEcCtD
Thioridazine—Thrombocytopenia—Bleomycin—melanoma	0.000844	0.00554	CcSEcCtD
Thioridazine—Vision blurred—Temozolomide—melanoma	0.00084	0.00551	CcSEcCtD
Thioridazine—Tremor—Temozolomide—melanoma	0.000835	0.00548	CcSEcCtD
Thioridazine—Leukopenia—Carmustine—melanoma	0.000826	0.00541	CcSEcCtD
Thioridazine—Anaemia—Temozolomide—melanoma	0.000824	0.0054	CcSEcCtD
Thioridazine—Anorexia—Bleomycin—melanoma	0.000822	0.00539	CcSEcCtD
Thioridazine—Agitation—Temozolomide—melanoma	0.000819	0.00537	CcSEcCtD
Thioridazine—Angioedema—Temozolomide—melanoma	0.000815	0.00534	CcSEcCtD
Thioridazine—Pancytopenia—Docetaxel—melanoma	0.000808	0.0053	CcSEcCtD
Thioridazine—Hypotension—Bleomycin—melanoma	0.000806	0.00528	CcSEcCtD
Thioridazine—Oedema—Dactinomycin—melanoma	0.000804	0.00527	CcSEcCtD
Thioridazine—Leukopenia—Temozolomide—melanoma	0.000798	0.00523	CcSEcCtD
Thioridazine—Thrombocytopenia—Dactinomycin—melanoma	0.000788	0.00516	CcSEcCtD
Thioridazine—Weight increased—Docetaxel—melanoma	0.000774	0.00508	CcSEcCtD
Thioridazine—Anorexia—Dactinomycin—melanoma	0.000767	0.00503	CcSEcCtD
Thioridazine—Confusional state—Carmustine—melanoma	0.000759	0.00498	CcSEcCtD
Thioridazine—Oedema—Carmustine—melanoma	0.000753	0.00494	CcSEcCtD
Thioridazine—Decreased appetite—Bleomycin—melanoma	0.00075	0.00492	CcSEcCtD
Thioridazine—Jaundice—Docetaxel—melanoma	0.000739	0.00485	CcSEcCtD
Thioridazine—Thrombocytopenia—Carmustine—melanoma	0.000737	0.00483	CcSEcCtD
Thioridazine—Tachycardia—Carmustine—melanoma	0.000735	0.00482	CcSEcCtD
Thioridazine—Confusional state—Temozolomide—melanoma	0.000734	0.00481	CcSEcCtD
Thioridazine—Oedema—Temozolomide—melanoma	0.000728	0.00477	CcSEcCtD
Thioridazine—Anorexia—Carmustine—melanoma	0.000718	0.00471	CcSEcCtD
Thioridazine—Thrombocytopenia—Temozolomide—melanoma	0.000712	0.00467	CcSEcCtD
Thioridazine—Feeling abnormal—Bleomycin—melanoma	0.000711	0.00466	CcSEcCtD
Thioridazine—Agranulocytosis—Docetaxel—melanoma	0.000708	0.00464	CcSEcCtD
Thioridazine—Hypotension—Carmustine—melanoma	0.000704	0.00461	CcSEcCtD
Thioridazine—Hyperhidrosis—Temozolomide—melanoma	0.000703	0.00461	CcSEcCtD
Thioridazine—Decreased appetite—Dactinomycin—melanoma	0.000699	0.00459	CcSEcCtD
Thioridazine—Anorexia—Temozolomide—melanoma	0.000694	0.00455	CcSEcCtD
Thioridazine—Body temperature increased—Bleomycin—melanoma	0.000682	0.00447	CcSEcCtD
Thioridazine—Oedema peripheral—Docetaxel—melanoma	0.000671	0.0044	CcSEcCtD
Thioridazine—Somnolence—Carmustine—melanoma	0.000669	0.00439	CcSEcCtD
Thioridazine—Feeling abnormal—Dactinomycin—melanoma	0.000663	0.00435	CcSEcCtD
Thioridazine—Decreased appetite—Carmustine—melanoma	0.000654	0.00429	CcSEcCtD
Thioridazine—Somnolence—Temozolomide—melanoma	0.000647	0.00424	CcSEcCtD
Thioridazine—Constipation—Carmustine—melanoma	0.000644	0.00422	CcSEcCtD
Thioridazine—Body temperature increased—Dactinomycin—melanoma	0.000636	0.00417	CcSEcCtD
Thioridazine—Hypersensitivity—Bleomycin—melanoma	0.000635	0.00417	CcSEcCtD
Thioridazine—Decreased appetite—Temozolomide—melanoma	0.000632	0.00415	CcSEcCtD
Thioridazine—Constipation—Temozolomide—melanoma	0.000622	0.00408	CcSEcCtD
Thioridazine—Feeling abnormal—Carmustine—melanoma	0.00062	0.00407	CcSEcCtD
Thioridazine—Arrhythmia—Docetaxel—melanoma	0.000608	0.00399	CcSEcCtD
Thioridazine—Feeling abnormal—Temozolomide—melanoma	0.0006	0.00393	CcSEcCtD
Thioridazine—Mental disorder—Docetaxel—melanoma	0.000597	0.00391	CcSEcCtD
Thioridazine—Body temperature increased—Carmustine—melanoma	0.000595	0.0039	CcSEcCtD
Thioridazine—Erythema—Docetaxel—melanoma	0.000593	0.00389	CcSEcCtD
Thioridazine—Hypersensitivity—Dactinomycin—melanoma	0.000593	0.00389	CcSEcCtD
Thioridazine—Body temperature increased—Temozolomide—melanoma	0.000575	0.00377	CcSEcCtD
Thioridazine—Hypersensitivity—Carmustine—melanoma	0.000555	0.00364	CcSEcCtD
Thioridazine—Diarrhoea—Dactinomycin—melanoma	0.00055	0.00361	CcSEcCtD
Thioridazine—Vomiting—Bleomycin—melanoma	0.000548	0.0036	CcSEcCtD
Thioridazine—Anaemia—Docetaxel—melanoma	0.000548	0.00359	CcSEcCtD
Thioridazine—Rash—Bleomycin—melanoma	0.000544	0.00357	CcSEcCtD
Thioridazine—Dermatitis—Bleomycin—melanoma	0.000543	0.00356	CcSEcCtD
Thioridazine—Hypersensitivity—Temozolomide—melanoma	0.000536	0.00351	CcSEcCtD
Thioridazine—Leukopenia—Docetaxel—melanoma	0.000531	0.00348	CcSEcCtD
Thioridazine—Diarrhoea—Carmustine—melanoma	0.000515	0.00338	CcSEcCtD
Thioridazine—Nausea—Bleomycin—melanoma	0.000512	0.00336	CcSEcCtD
Thioridazine—Vomiting—Dactinomycin—melanoma	0.000511	0.00335	CcSEcCtD
Thioridazine—Rash—Dactinomycin—melanoma	0.000507	0.00333	CcSEcCtD
Thioridazine—Diarrhoea—Temozolomide—melanoma	0.000498	0.00326	CcSEcCtD
Thioridazine—Confusional state—Docetaxel—melanoma	0.000488	0.0032	CcSEcCtD
Thioridazine—Oedema—Docetaxel—melanoma	0.000484	0.00317	CcSEcCtD
Thioridazine—Vomiting—Carmustine—melanoma	0.000479	0.00314	CcSEcCtD
Thioridazine—Nausea—Dactinomycin—melanoma	0.000478	0.00313	CcSEcCtD
Thioridazine—Rash—Carmustine—melanoma	0.000475	0.00311	CcSEcCtD
Thioridazine—Dermatitis—Carmustine—melanoma	0.000474	0.00311	CcSEcCtD
Thioridazine—Thrombocytopenia—Docetaxel—melanoma	0.000474	0.00311	CcSEcCtD
Thioridazine—Tachycardia—Docetaxel—melanoma	0.000472	0.0031	CcSEcCtD
Thioridazine—Headache—Carmustine—melanoma	0.000472	0.00309	CcSEcCtD
Thioridazine—Vomiting—Temozolomide—melanoma	0.000463	0.00303	CcSEcCtD
Thioridazine—Anorexia—Docetaxel—melanoma	0.000461	0.00302	CcSEcCtD
Thioridazine—Rash—Temozolomide—melanoma	0.000459	0.00301	CcSEcCtD
Thioridazine—Dermatitis—Temozolomide—melanoma	0.000458	0.00301	CcSEcCtD
Thioridazine—Headache—Temozolomide—melanoma	0.000456	0.00299	CcSEcCtD
Thioridazine—Hypotension—Docetaxel—melanoma	0.000452	0.00296	CcSEcCtD
Thioridazine—Nausea—Carmustine—melanoma	0.000447	0.00293	CcSEcCtD
Thioridazine—Nausea—Temozolomide—melanoma	0.000432	0.00283	CcSEcCtD
Thioridazine—Somnolence—Docetaxel—melanoma	0.00043	0.00282	CcSEcCtD
Thioridazine—Decreased appetite—Docetaxel—melanoma	0.000421	0.00276	CcSEcCtD
Thioridazine—Constipation—Docetaxel—melanoma	0.000414	0.00271	CcSEcCtD
Thioridazine—Feeling abnormal—Docetaxel—melanoma	0.000399	0.00261	CcSEcCtD
Thioridazine—Body temperature increased—Docetaxel—melanoma	0.000382	0.00251	CcSEcCtD
Thioridazine—Hypersensitivity—Docetaxel—melanoma	0.000356	0.00234	CcSEcCtD
Thioridazine—Diarrhoea—Docetaxel—melanoma	0.000331	0.00217	CcSEcCtD
Thioridazine—Vomiting—Docetaxel—melanoma	0.000308	0.00202	CcSEcCtD
Thioridazine—Rash—Docetaxel—melanoma	0.000305	0.002	CcSEcCtD
Thioridazine—Dermatitis—Docetaxel—melanoma	0.000305	0.002	CcSEcCtD
Thioridazine—Headache—Docetaxel—melanoma	0.000303	0.00199	CcSEcCtD
Thioridazine—Nausea—Docetaxel—melanoma	0.000287	0.00188	CcSEcCtD
Thioridazine—Eletriptan—ABCB1—melanoma	0.000146	0.125	CrCbGaD
Thioridazine—Triflupromazine—ABCB1—melanoma	0.000111	0.0949	CrCbGaD
Thioridazine—Acepromazine—ALB—melanoma	0.000108	0.092	CrCbGaD
Thioridazine—Thioproperazine—ALB—melanoma	0.000105	0.0899	CrCbGaD
Thioridazine—Thiothixene—ALB—melanoma	0.000103	0.0885	CrCbGaD
Thioridazine—Pipotiazine—ALB—melanoma	0.000103	0.0885	CrCbGaD
Thioridazine—Fluphenazine—ABCB1—melanoma	8.54e-05	0.073	CrCbGaD
Thioridazine—Clomipramine—ALB—melanoma	8.18e-05	0.0699	CrCbGaD
Thioridazine—Clomipramine—ABCB1—melanoma	7.81e-05	0.0667	CrCbGaD
Thioridazine—Promethazine—ABCB1—melanoma	6.92e-05	0.0591	CrCbGaD
Thioridazine—Trifluoperazine—ABCB1—melanoma	6.82e-05	0.0583	CrCbGaD
Thioridazine—Chlorpromazine—ALB—melanoma	5.61e-05	0.048	CrCbGaD
Thioridazine—Chlorpromazine—ABCB1—melanoma	5.35e-05	0.0458	CrCbGaD
Thioridazine—ADRA1A—Signaling by GPCR—HRAS—melanoma	8.75e-06	2.96e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CASP3—melanoma	8.75e-06	2.96e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL2—melanoma	8.74e-06	2.95e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—AKT1—melanoma	8.7e-06	2.94e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—IL6—melanoma	8.69e-06	2.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—AKT1—melanoma	8.69e-06	2.93e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—melanoma	8.67e-06	2.93e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—melanoma	8.66e-06	2.93e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—melanoma	8.63e-06	2.92e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—ERBB2—melanoma	8.63e-06	2.91e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1B—melanoma	8.62e-06	2.91e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—melanoma	8.62e-06	2.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—melanoma	8.61e-06	2.91e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1B—melanoma	8.6e-06	2.91e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—melanoma	8.6e-06	2.9e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—melanoma	8.59e-06	2.9e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—melanoma	8.59e-06	2.9e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—melanoma	8.58e-06	2.9e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—melanoma	8.55e-06	2.89e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—melanoma	8.53e-06	2.88e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—melanoma	8.53e-06	2.88e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—melanoma	8.52e-06	2.88e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—melanoma	8.52e-06	2.88e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—melanoma	8.51e-06	2.87e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—melanoma	8.46e-06	2.86e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—melanoma	8.45e-06	2.86e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—melanoma	8.44e-06	2.85e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CTNNB1—melanoma	8.43e-06	2.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—melanoma	8.43e-06	2.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—melanoma	8.42e-06	2.84e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—melanoma	8.41e-06	2.84e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—melanoma	8.4e-06	2.84e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—melanoma	8.38e-06	2.83e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—melanoma	8.37e-06	2.83e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—melanoma	8.37e-06	2.83e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—melanoma	8.36e-06	2.82e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—melanoma	8.36e-06	2.82e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PPARG—melanoma	8.36e-06	2.82e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—melanoma	8.35e-06	2.82e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—melanoma	8.33e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—melanoma	8.31e-06	2.81e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CTNNB1—melanoma	8.3e-06	2.8e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PPARG—melanoma	8.29e-06	2.8e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CTNNB1—melanoma	8.28e-06	2.8e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—melanoma	8.28e-06	2.8e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MMP9—melanoma	8.27e-06	2.79e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—melanoma	8.25e-06	2.79e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—melanoma	8.25e-06	2.79e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1A—melanoma	8.24e-06	2.78e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—melanoma	8.23e-06	2.78e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—melanoma	8.22e-06	2.78e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—melanoma	8.2e-06	2.77e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CXCL8—melanoma	8.18e-06	2.76e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NFKB1—melanoma	8.18e-06	2.76e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—melanoma	8.17e-06	2.76e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CTNNB1—melanoma	8.15e-06	2.75e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MMP9—melanoma	8.14e-06	2.75e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—melanoma	8.13e-06	2.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CTNNB1—melanoma	8.13e-06	2.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MMP9—melanoma	8.12e-06	2.74e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1A—melanoma	8.11e-06	2.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1A—melanoma	8.09e-06	2.73e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—melanoma	8.09e-06	2.73e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—melanoma	8.08e-06	2.73e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—melanoma	8.08e-06	2.73e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—melanoma	8.07e-06	2.73e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—melanoma	8.05e-06	2.72e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NFKB1—melanoma	8.05e-06	2.72e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NFKB1—melanoma	8.03e-06	2.71e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—melanoma	8.02e-06	2.71e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTGS2—melanoma	8.01e-06	2.71e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—melanoma	8e-06	2.7e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1B—melanoma	7.99e-06	2.7e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MMP9—melanoma	7.99e-06	2.7e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—melanoma	7.97e-06	2.69e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MMP9—melanoma	7.97e-06	2.69e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1A—melanoma	7.96e-06	2.69e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—melanoma	7.96e-06	2.69e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—melanoma	7.95e-06	2.69e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—melanoma	7.94e-06	2.68e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1A—melanoma	7.94e-06	2.68e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—melanoma	7.92e-06	2.67e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—melanoma	7.9e-06	2.67e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NFKB1—melanoma	7.9e-06	2.67e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—melanoma	7.9e-06	2.67e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—melanoma	7.89e-06	2.67e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—melanoma	7.89e-06	2.67e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NFKB1—melanoma	7.88e-06	2.66e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—melanoma	7.87e-06	2.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—melanoma	7.83e-06	2.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—melanoma	7.82e-06	2.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—melanoma	7.78e-06	2.63e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—melanoma	7.78e-06	2.63e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—melanoma	7.75e-06	2.62e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—melanoma	7.74e-06	2.61e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—melanoma	7.73e-06	2.61e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.69e-06	2.6e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—melanoma	7.68e-06	2.59e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—melanoma	7.62e-06	2.58e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—melanoma	7.62e-06	2.57e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—melanoma	7.61e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK1—melanoma	7.61e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EGFR—melanoma	7.61e-06	2.57e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK1—melanoma	7.57e-06	2.56e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EGFR—melanoma	7.57e-06	2.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CTNNB1—melanoma	7.55e-06	2.55e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—melanoma	7.55e-06	2.55e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—melanoma	7.52e-06	2.54e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—melanoma	7.45e-06	2.52e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—melanoma	7.43e-06	2.51e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—melanoma	7.42e-06	2.51e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—melanoma	7.41e-06	2.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MMP9—melanoma	7.4e-06	2.5e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1A—melanoma	7.37e-06	2.49e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—melanoma	7.36e-06	2.49e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—melanoma	7.35e-06	2.48e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—melanoma	7.34e-06	2.48e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—melanoma	7.33e-06	2.48e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NFKB1—melanoma	7.32e-06	2.47e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—melanoma	7.31e-06	2.47e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—melanoma	7.29e-06	2.46e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—melanoma	7.29e-06	2.46e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—melanoma	7.28e-06	2.46e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK1—melanoma	7.25e-06	2.45e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EGFR—melanoma	7.25e-06	2.45e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—melanoma	7.23e-06	2.44e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—melanoma	7.22e-06	2.44e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—melanoma	7.22e-06	2.44e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—melanoma	7.21e-06	2.44e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—melanoma	7.2e-06	2.43e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—melanoma	7.19e-06	2.43e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—melanoma	7.18e-06	2.42e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—melanoma	7.17e-06	2.42e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—melanoma	7.15e-06	2.42e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—melanoma	7.15e-06	2.42e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTGS2—melanoma	7.15e-06	2.41e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—melanoma	7.11e-06	2.4e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—melanoma	7.1e-06	2.4e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—melanoma	7.08e-06	2.39e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—melanoma	7.08e-06	2.39e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PPARG—melanoma	7.08e-06	2.39e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—melanoma	7.07e-06	2.39e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—melanoma	7.02e-06	2.37e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—melanoma	6.98e-06	2.36e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—melanoma	6.91e-06	2.33e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—melanoma	6.9e-06	2.33e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—melanoma	6.85e-06	2.31e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—melanoma	6.83e-06	2.31e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—melanoma	6.8e-06	2.3e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—melanoma	6.79e-06	2.29e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—melanoma	6.77e-06	2.29e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—melanoma	6.72e-06	2.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—melanoma	6.71e-06	2.27e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK1—melanoma	6.68e-06	2.26e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EGFR—melanoma	6.68e-06	2.26e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—melanoma	6.65e-06	2.24e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—melanoma	6.64e-06	2.24e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—melanoma	6.6e-06	2.23e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—melanoma	6.6e-06	2.23e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—melanoma	6.58e-06	2.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—melanoma	6.58e-06	2.22e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—melanoma	6.58e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK1—melanoma	6.58e-06	2.22e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTGS2—melanoma	6.58e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EGFR—melanoma	6.57e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—melanoma	6.57e-06	2.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—melanoma	6.56e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK1—melanoma	6.56e-06	2.22e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EGFR—melanoma	6.56e-06	2.22e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTGS2—melanoma	6.52e-06	2.2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK1—melanoma	6.46e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EGFR—melanoma	6.45e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—melanoma	6.45e-06	2.18e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK1—melanoma	6.44e-06	2.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EGFR—melanoma	6.44e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—melanoma	6.39e-06	2.16e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—melanoma	6.37e-06	2.15e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—melanoma	6.36e-06	2.15e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—melanoma	6.31e-06	2.13e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—melanoma	6.29e-06	2.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—melanoma	6.29e-06	2.12e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—melanoma	6.27e-06	2.12e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—melanoma	6.23e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—melanoma	6.21e-06	2.1e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—melanoma	6.21e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—melanoma	6.2e-06	2.09e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—melanoma	6.11e-06	2.07e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—melanoma	6.11e-06	2.06e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—melanoma	6.1e-06	2.06e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—melanoma	6.08e-06	2.06e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—melanoma	6.08e-06	2.05e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—melanoma	6.08e-06	2.05e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK1—melanoma	5.98e-06	2.02e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EGFR—melanoma	5.98e-06	2.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—melanoma	5.85e-06	1.98e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—melanoma	5.82e-06	1.97e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—melanoma	5.82e-06	1.97e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—melanoma	5.8e-06	1.96e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—melanoma	5.73e-06	1.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—melanoma	5.71e-06	1.93e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—melanoma	5.7e-06	1.93e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—melanoma	5.69e-06	1.92e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—melanoma	5.68e-06	1.92e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—melanoma	5.65e-06	1.91e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—melanoma	5.62e-06	1.9e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—melanoma	5.61e-06	1.89e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—melanoma	5.6e-06	1.89e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—melanoma	5.59e-06	1.89e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTGS2—melanoma	5.57e-06	1.88e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—melanoma	5.57e-06	1.88e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—melanoma	5.52e-06	1.86e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—melanoma	5.51e-06	1.86e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—melanoma	5.42e-06	1.83e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—melanoma	5.4e-06	1.83e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—melanoma	5.4e-06	1.82e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—melanoma	5.37e-06	1.81e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—melanoma	5.36e-06	1.81e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—melanoma	5.28e-06	1.78e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—melanoma	5.27e-06	1.78e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—melanoma	5.19e-06	1.75e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—melanoma	5.18e-06	1.75e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—melanoma	5.17e-06	1.75e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—melanoma	5.14e-06	1.74e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—melanoma	5.13e-06	1.73e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—melanoma	5.07e-06	1.71e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—melanoma	5.05e-06	1.71e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—melanoma	5.04e-06	1.7e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—melanoma	5.02e-06	1.7e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—melanoma	4.96e-06	1.68e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—melanoma	4.95e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—melanoma	4.93e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—melanoma	4.86e-06	1.64e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—melanoma	4.8e-06	1.62e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—melanoma	4.74e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—melanoma	4.66e-06	1.57e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—melanoma	4.66e-06	1.57e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—melanoma	4.65e-06	1.57e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—melanoma	4.6e-06	1.55e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—melanoma	4.58e-06	1.55e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—melanoma	4.56e-06	1.54e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—melanoma	4.4e-06	1.49e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—melanoma	4.24e-06	1.43e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—melanoma	4.05e-06	1.37e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—melanoma	4.03e-06	1.36e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—melanoma	4.01e-06	1.35e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—melanoma	3.59e-06	1.21e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—melanoma	3.43e-06	1.16e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—melanoma	3.3e-06	1.12e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—melanoma	3.28e-06	1.11e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—melanoma	2.8e-06	9.46e-06	CbGpPWpGaD
